Body mass index and musculoskeletal pain: Is there a connection?

Chiropractic and Manual Therapies

Volumn 21, Issue 1, 2013, Pages

  Seaman, David R ^a  

^a NATIONAL UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Back pain; Body mass index; Inflammation; Metabolic syndrome; Obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECOMBINANT ADIPONECTIN; RECOMBINANT INTERLEUKIN 10; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANTHROPOMETRY; BEHAVIOR CHANGE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHIROPRACTIC; CHIROPRACTOR; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CHRONIC SYSTEMIC INFLAMMATION; CLINICAL PRACTICE; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ASSOCIATION; EXERCISE; HUMAN; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LOW BACK PAIN; METABOLIC SYNDROME X; MUSCULOSKELETAL PAIN; NOTE; OBESITY; OSTEOARTHRITIS; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION;

EID: 84877843037     PISSN: None     EISSN: 2045709X     Source Type: Journal    
DOI: 10.1186/2045-709X-21-15     Document Type: Note

References (153)

1. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005, 81:341-354.
2. Bays HE, Gonzalez-Campoy M, Henry RR, Bergman DA, Kitabchi AE, Schorr AB, Rodbard HW. Is adiposopathy (sick fat) an endocrine disease?. Int J Clin Pract 2008, 62:1474-1483. 10.1111/j.1742-1241.2008.01848.x, 2658008, 18681905.
3. Leboeuf-Yde C. Body weight and low back pain. A systematic literature review of 56 journal articles reporting on 65 epidemiologic studies. Spine 2000, 25:226-237. 10.1097/00007632-200001150-00015, 10685488.
4. Chou R, Qaseem A, Snow V, Casey D, Cross JT, Shekelle P, Owens DK. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007, 147:478-491. 10.7326/0003-4819-147-7-200710020-00006, 17909209.
5. Bouwmeester W, van Enst A, van Tulder M. Quality of low back pain guidelines improved. Spine 2009, 34:2562-2567. 10.1097/BRS.0b013e3181b4d50d, 19841612.
6. Rubin DI. Epidemiology and risk factors for spine pain. Neurol Clin 2007, 25:353-371. 10.1016/j.ncl.2007.01.004, 17445733.
7. Lebovits A, Hainline B, Stone LS, Seminowicz DA, Brunz JT, Rosenquist RW, Cowan P. Struck from behind: maintaining quality of life with chronic low back pain. J Pain 2009, 10:927-931. 10.1016/j.jpain.2009.06.011, 19712900.
8. Stone AA, Broderick JE. Obesity and pain are associated in the United States. Obesity 2012, 20:1491-1495. 10.1038/oby.2011.397, 22262163.
9. Wright LJ, Schur E, Noonan C, Ahumada S, Buchwald D, Afari N. Chronic pain, overweight, and obesity: findings from a community-based twin registry. J Pain 2010, 11:628-635. 10.1016/j.jpain.2009.10.004, 2892725, 20338816.
10. Shiri R, Karppinen J, Leino-Arjas P, Solovieva S, Viikari-Juntura E. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol 2010, 171:135-154. 10.1093/aje/kwp356, 20007994.
11. Heuch I, Hagen K, Heuch I, Nygaard T, Zwart JA. The impact of body mass index on the prevalence of low back pain: the HUNT study. Spine 2010, 35:764-768.
12. Heuch I, Heuch I, Hagen K, Zwart JA. Body mass index as a risk factor for developing chronic low back pain: A Follow-up in the Nord-Trøndelag Health Study. Spine 2012, [Epub ahead of print].
13. Briggs MS, Givens DL, Schmitt LC, Taylor CA. The relationships of C-reactive protein and obesity to the prevalence and odds of reporting low back pain. Arch Phys Med Rehabil 2012, S0003-9993(12):01187-09993. Epub ahead of print].
14. Mantyselka P, Miettola J, Niskanen L, Kumpusalo E. Persistent pain at multiple sites-connection to glucose derangement. Diabetes Res Clin Pract 2009, 84(2):e30-e32. 10.1016/j.diabres.2009.01.018, 19250695.
15. Mantyselka P, Miettola J, Niskanen L, Kumpusalo E. Glucose regulation and chronic pain at multiple sites. Rheumatology 2008, 47:1235-1238. 10.1093/rheumatology/ken220, 18550637.
16. Mantyselka P, Miettola J, Niskanen L, Kumpusalo E. Chronic pain, impaired glucose tolerance and diabetes: a community-based study. Pain 2008, 137:34-40. 10.1016/j.pain.2007.08.007, 17869422.
17. Mantyselka P, Kautianen H, Vanhala M. Prevalence of neck pain in subjects with metabolic syndrome - a cross-sectional population-based study. BMC Musculoskelet Disord 2010, 11:171. 10.1186/1471-2474-11-171, 2918543, 20670458.
18. Rechardt M, Shiri R, Karppinen J, Jula A, Heliövaara M, Viikari-Juntura E. Lifestyle and metabolic factors in relation to shoulder pain and rotator cuff tendinitis: A population-based study. BMC Musculoskelet Disord 2010, 11:165. 10.1186/1471-2474-11-165, 3161397, 20646281.
19. Gaida JE, Alfredson L, Kiss ZS, Wilson AM, Alfredson H, Cook JL. Dyslipidemia in Achilles tendinopathy is characteristic of insulin resistance. Med Sci Sports Exerc 2009, 41:1194-1197. 10.1249/MSS.0b013e31819794c3, 19461549.
20. Malliaras P, Cook JL, Kent PM. Anthropometric risk factors for patellar tendon injury among volleyball players. Br J Sports Med 2007, 41:259-263. 10.1136/bjsm.2006.030049, 2658960, 16920767.
21. Shiri R, Viikari-Juntura E, Varonen H, Heliovaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol 2006, 164:1065-1074. 10.1093/aje/kwj325, 16968862.
22. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Cardiovascular risk factors for physician-diagnosed lumbar disc herniation. Spine J 2006, 6:684-691. 10.1016/j.spinee.2006.04.016, 17088199.
23. Kauppila LI, McAlindon T, Evans S, Wilson PW, Kiel D, Felson DT. Disc degeneration/back pain and calcification of the abdominal aorta: a 25-year follow-up study in Framingham. Spine 1997, 22:1642-1647. 10.1097/00007632-199707150-00023, 9253101.
24. Kurunlahti M, Tervonen O, Vanharanta H, Ilkko E, Suramo I. Association of atherosclerosis with low back pain and the degree of disc degeneration. Spine 1999, 24:2080-2084. 10.1097/00007632-199910150-00003, 10543002.
25. Kauppila LI, Mikkonen R, Mankinen P, Pelto-Vasenius K, Mäenpää I. MR aortography and serum cholesterol levels in patients with long-term non-specific lower back pain. Spine 2004, 29:2347-2352.
26. Leino-Arjas P, Kaila-Kangas L, Solovieva S, Riihimäki H, Kirjonen J, Reunanen A. Serum lipids and low back pain: an association? A follow-up study of a working population sample. Spine 2006, 31:1032-1037. 10.1097/01.brs.0000214889.31505.08, 16641781.
27. Leino-Arjas P, Solovieva S, Kirjonen J, Reunanen A, Riihimäki H. Cardiovascular risk factors and low-back pain in a long-term follow-up of industrial employees. Scand J Work Environ Health 2006, 32:12-19. 10.5271/sjweh.971, 16539167.
28. Shiri R, Karppinen J, Leino-Arjas P, Solovieva S, Varonen H, Kalso E, Ukkola O, Viikari-Juntura E. Cardiovascular and lifestyle risk factors in lumbar radicular pain or clinically defined sciatica: a systematic review. Eur Spine J 2007, 16:2043-2054. 10.1007/s00586-007-0362-6, 2140143, 17525856.
29. Leino-Arjas P, Kauppila L, Kaila-Kangas L, Shiri R, Heistaro S, Heliövaara M. Serum lipids in relation to sciatica among Finns. Atherosclerosis 2008, 197:43-49. 10.1016/j.atherosclerosis.2007.07.035, 17825307.
30. Kauppila LI. Atherosclerosis and disc degeneration/low back pain - a systematic review. Eur J Vasc Endovasc Surg 2009, 37:661-670. 10.1016/j.ejvs.2009.02.006, 19328027.
31. Heuch I, Heuch I, Hagen K, Zwart JA. Associations between serum lipid levels and chronic low back pain. Epidemiology 2010, 21:837-841. 10.1097/EDE.0b013e3181f20808, 20798637.
32. Conaghan PG, Vanharanta H, Dieppe PA. Is progressive osteoarthritis an atheromatous vascular disease?. Ann Rheum Dis 2005, 64:1539-1541. 10.1136/ard.2005.039263, 1755271, 16107512.
33. Masuko K, Murata M, Suematsu N, Okamoto K, Yudoh K, Nakamura H, Kato T. A metabolic aspect of osteoarthritis: lipid as a possible contributor to the pathogenesis of cartilage degradation. Clin Exp Rheumatol 2009, 27:347-353.
34. Gkretsi V, Simopoulou T, Tsezou A. Lipid metabolism and osteoarthritis: lessons from atherosclerosis. Prog Lipid Res 2011, 50:133-140. 10.1016/j.plipres.2010.11.001, 21115041.
35. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis). Osteoarthr Cartil 2013, 21:16-21. 10.1016/j.joca.2012.11.012, 23194896.
36. Abate M, Schiavone C, Pelotti P, Salini V. Limited joint mobility (LJM) in elderly subjects with type II diabetes mellitus. Arch Gerontol Geriatrics 2011, 53:135-140.
37. Lotan R, Oron A, Anekstein Y, Shalmon E, Mirovsky Y. Lumbar stenosis and systemic diseases: is there any relevance. J Spinal Disord Tech 2008, 21:247-251. 10.1097/BSD.0b013e31813707af, 18525484.
38. Anekstein Y, Smorgick Y, Lotan R, Agar G, Shalmon E, Floman Y, Mirovsky Y. Diabetes mellitus as a risk factor for the development of lumbar spinal stenosis. Isr Med Assoc J 2010, 12:16-20.
39. Sakellaridis N. The influence of diabetes mellitus on lumbar intervertebral disk herniation. Surg Neurol 2006, 66:152-154. 10.1016/j.surneu.2006.01.019, 16876608.
40. Sakellaridis N, Androulis A. Influence of diabetes mellitus on cervical intervertebral disc herniation. Clin Neurol Neurosurg 2008, 110:810-812. 10.1016/j.clineuro.2008.05.007, 18573593.
41. Bays HE. Adiposopathy: is sick fat a cardiovascular disease?. J Am Coll Cardiol 2011, 57:2461-2473. 10.1016/j.jacc.2011.02.038, 21679848.
42. Bays H. Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating "sick fat" through improving fat function with antidiabetes therapies. Am J Cardiol 2012, 110(suppl):4B-12B.
43. Sommer C, Birklein F. Resolvins and inflammatory pain. F1000 Med Rep 2011, 3:19. 10.3410/M3-19, 3186038, 22003366.
44. Sommer C, Birklein F. Fighting off pain with resolvins. Nat Med 2010, 16(5):518-520. 10.1038/nm0510-518, 20448572.
45. Ji RR, Xu ZZ, Strichartz G, Serhan CN. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 2011, 34:599-609. 10.1016/j.tins.2011.08.005, 3200462, 21963090.
46. Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji RR. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 2010, 16:592-597. 10.1038/nm.2123, 2866054, 20383154.
47. Nathan C, Ding A. Nonresolving inflammation. Cell 2010, 140:871-882. 10.1016/j.cell.2010.02.029, 20303877.
48. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007, 21:325-332. 10.1096/fj.06-7227rev, 3119634, 17267386.
49. Zhang MJ, Spite M. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr 2012, 32:203-227. 10.1146/annurev-nutr-071811-150726, 22404117.
50. Campbell EL, Serhan CN, Colgan SP. Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators. J Immunol 2011, 187:3475-3481. 10.4049/jimmunol.1100150, 3362457, 21934099.
51. Das UN. Is multiple sclerosis a proresolution deficiency disorder?. Nutrition 2012, 28:951-958. 10.1016/j.nut.2011.12.016, 22521616.
52. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126. 10.1056/NEJM199901143400207, 9887164.
53. Biasucci LM, Colizzi C, Rizzello V, Vitrella G, Crea F, Liuzzo G. Role of inflammation in the pathogenesis of unstable coronary artery diseases. Scand J Clin Lab Invest Suppl 1999, 230:12-22.
54. Das UN. Is obesity and inflammatory condition?. Nutrition 2001, 17:953-966. 10.1016/S0899-9007(01)00672-4, 11744348.
55. Seaman DR. The diet-induced pro-inflammatory state: a cause of chronic pain and other degenerative diseases?. J Manip Physiol Ther 2002, 25:168-179.
56. Ridker PM. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003, 108:81-85.
57. Nicklas BJ, You T, Pahor M. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ 2005, 172:1199-1209. 10.1503/cmaj.1040769, 557073, 15851714.
58. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440-1446. 10.1001/jama.292.12.1440, 15383514.
59. Esposito K, Giugliano D. Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J 2006, 27:15-20.
60. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006, 48:677-685. 10.1016/j.jacc.2006.03.052, 16904534.
61. Basu A, Devaraj S, Jialol I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 2006, 26:995-1001. 10.1161/01.ATV.0000214295.86079.d1, 16484595.
62. O'Keefe JH, Bell DS. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 2007, 100:899-904. 10.1016/j.amjcard.2007.03.107, 17719342.
63. O'Keefe JH, Gheewala NM, O'Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 2008, 51:249-255. 10.1016/j.jacc.2007.10.016, 18206731.
64. Frassetto LA, Schloetter M, Mietus-Synder M, Morris RC, Sebastian A. Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet. Eur J Clin Nutr 2009, 63:947-955. 10.1038/ejcn.2009.4, 19209185.
65. Egger G, Dixon J. Inflammatory effects of nutritional stimuli: further support for the need for a big picture approach to tackling obesity and chronic disease. Obes Rev 2010, 11:137-149. 10.1111/j.1467-789X.2009.00644.x, 19656309.
66. Guyton AC, Hall JE. Textbook of medical physiology 2011, Philadelphia: Saunders.
67. Robbins & Cotran Pathologic Basis of Disease 2010, Philadelphia: Saunders, Kumar V, Abbas AK, Fausto N, Aster J, 8.
68. Bonner WM, Jonsson H, Malanos C, Bryant M. Changes in lipids of human articular cartilage with age. Arthritis Rheum 1975, 18:461-473. 10.1002/art.1780180505, 1191347.
69. Goldenberg DL, Egan MS, Cohen AS. Inflammatory synovitis in degenerative joint disease. J Rheumatol 1982, 9:204-209.
70. Adkisson HD, Risener FS, Zarrinkar PP, Walla MD, Christie WW, Wuthier RE. Unique fatty acid composition of normal cartilage: discovery of high levels of n-9 eicosatrienoic acid and low levels of n-6 polyunsaturated fatty acids. FASEB J 1991, 5:344-353.
71. Nakamura H, Yoshino S, Kato T, Tsuruha J, Nishioka K. T-cell mediated inflammatory pathway in osteoarthritis. Osteoarthritis Cart 1999, 7:401-402.
72. Nishioka K. Autoimmune response in cartilage-derived peptides in a patient with osteoarthritis. Arth Res Ther 2003, 6:6-7.
73. Kato T, Xiang Y, Nakamura H, Nishioka K. Neoantigens in osteoarthritic cartilage. Curr Opin Rheumatol 2004, 16:604-608. 10.1097/01.bor.0000133661.52599.bf, 15314502.
74. Lamon BD, Hajjar DP. Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol 2008, 173:1253-1264. 10.2353/ajpath.2008.080442, 2570117, 18948435.
75. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology 2005, 44:7-16. 10.1093/rheumatology/keh344, 15292527.
76. Tiku ML, Shah R, Allison GT. Evidence link chondrocyte lipid peroxidation to cartilage matrix protein degradation: possible role in cartilage aging and the pathogenesis of osteoarthritis. J Biol Chem 2000, 275:20069-20076. 10.1074/jbc.M907604199, 10867027.
77. Tiku ML, Allison GT, Naik K, Karry SK. Malondialdehyde oxidation of cartilage collagen by chondrocytes. Osteoarthr Cartil 2003, 11:159-166. 10.1016/S1063-4584(02)00348-5, 12623287.
78. Sturmer T, Sun Y, Sauerland S, Zeissig I, Gunther KP, Puhl W, Brenner H. Serum cholesterol and osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study. J Rheumatol 1998, 25:1827-1832.
79. Maes M, Song C, Lin A, Van Gastel A, Kenis G, Bosmans E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpé S, Smith RS. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and TH-1 like response in stress-induced anxiety. Cytokine 1998, 10:313-318. 10.1006/cyto.1997.0290, 9617578.
80. Bierhaus A, Humpert PM, Nawroth PP. Linking stress to inflammation. Anesthesiol Clin N Am 2006, 24:325-340.
81. Simpson N, Dinges DF. Sleep and inflammation. Nutr Rev 2007, 65:S244-S252. 10.1301/nr.2007.dec.S244-S252, 18240557.
82. Irwin MR, Carrillo C, Omstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav Immunity 2010, 24:54-57.
83. Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, metabolic disease. Cell Metab 2011, 13:11-22. 10.1016/j.cmet.2010.12.008, 3040418, 21195345.
84. Ahn KS, Aggarwal BB. Transcription factor NF-κB: a sensor for smoke and stress signals. Ann NY Acad Sci 2005, 1056:218-233. 10.1196/annals.1352.026, 16387690.
85. Lekander M, Elofsson S, Neve IM, Hansson LO, Undén AL. Self-rated health is related to levels of circulating cytokines. Psychosom Med 2004, 66:559-563. 10.1097/01.psy.0000130491.95823.94, 15272103.
86. Christian LM, Glaser R, Porter K, Malarkey WB, Beversdorf D, Kiecolt-Glaser JK. Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology 2011, 36:1495-1504. 10.1016/j.psyneuen.2011.04.003, 3161147, 21601365.
87. Wium-Andersen MK, Orsted DD, Nielsen SF, Nordestgaard BG. Elevated C-reactive protein levels, psychological distress, and depression in 73,131 individuals. JAMA Psychiatry 2013, 70:176-184. 10.1001/2013.jamapsychiatry.102, 23266538.
88. Khairova RA, Machado-Vieira R, Du J, Manji HK. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 2009, 12:561-578. 10.1017/S1461145709009924, 2771334, 19224657.
89. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741. 10.1016/j.biopsych.2008.11.029, 2680424, 19150053.
90. Krishnadas R, Cavanagh J. Depression: an inflammatory illness?. J Neurol Neurosurg Psychiatry 2012, 83:495-502. 10.1136/jnnp-2011-301779, 22423117.
91. Irwin MR. Inflammation at the intersection of behavior and somatic symptoms. Psychiatr Clin N Am 2011, 34:605-620.
92. Bonaccorso S, Meltzer HY, Maes M. Psychological and behavioral effects of interferons. Curr Opin Psychiatry 2000, 13:673-677.
93. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56. 10.1038/nrn2297, 2919277, 18073775.
94. Spiegel K, Tasali E, Penev P, Van Cauter E. Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels and increased hunger and appetite. Ann Intern Med 2004, 141:846-850. 10.7326/0003-4819-141-11-200412070-00008, 15583226.
95. Knutson KL, Spiegel K, Penev P, van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007, 11:163-178. 10.1016/j.smrv.2007.01.002, 1991337, 17442599.
96. Morselli L, Leproult R, Balbo M, Spiegel K. Role of sleep duration in the regulation of glucose metabolism and appetite. Best Prac Res Clin Endocrinol Metab 2010, 24:687-702.
97. Lucassen EA, Rother KI, Cizza G. Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann NY Acad Sci 2012, 1264:110-134. 10.1111/j.1749-6632.2012.06655.x, 3418485, 22827862.
98. Dallman MF, Pecoraro NC, la Fleur SE. Chronic stress and comfort foods: self-medication and abdominal obesity. Brain Behav Immun 2005, 19:275-280. 10.1016/j.bbi.2004.11.004, 15944067.
99. Adam TC, Epe ES. Stress, eating and the reward system. Physiol Behav 2007, 91:449-458. 10.1016/j.physbeh.2007.04.011, 17543357.
100. Maniam J, Morris MJ. The link between stress and feeding behaviour. Neuropharmacol 2012, 63:97-110.
101. Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD. Insufficient sleep undermines dietary efforts to reduce obesity. Ann Int Med 2010, 153:435-441. 10.7326/0003-4819-153-7-201010050-00006, 2951287, 20921542.
102. Edwards R, Almeida DM, Klick B, Haythornthwaite JA, Smith MT. Duration of sleep contributes to next-day pain report in the general population. Pain 2008, 137:202-207. 10.1016/j.pain.2008.01.025, 2527580, 18434020.
103. Mullington JM, Simpson NS, Meier-Ewert HK, Haak M. Sleep loss and inflammation. Best Prac Res Clin Endocrinol Metab 2010, 24:775-784.
104. Motivala SJ. Sleep and inflammation. psychoneuroimmunology in the context of cardiovascular disease. Ann Behav Med 2011, 42:141-152. 10.1007/s12160-011-9280-2, 21604067.
105. Black PH. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypoth 2006, 67:879-891.
106. Petersen AM, Pedersen BK. The anti-inflammatory effects of exercise. J Appl Physiol 2005, 98:1154-1162. 10.1152/japplphysiol.00164.2004, 15772055.
107. Mathur N, Pedersen BK. Exercise as a means to control low-grade systemic inflammation. Mediators Inflamm 2008, 2008:109502. 2615833, 19148295.
108. Rethorst CD, Toups MS, Greer TL, Nakonezny PA, Carmody TJ, Brannermann BD, Huebinger RM, Barber RC, Trivedi MH. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol Psychiatry 2012, [Epub ahead of print].
109. Santos RV, Viana VA, Boscolo RA, Marques VG, Santana MG, Lira FS, Tufik S, de Mello MT. Moderate exercise training modulates cytokine profile and sleep in elderly people. Cytokine 2012, [Epub ahead of print].
110. Oliveira J, Páscoa Pinheiro J, Reis F,. Teixeira de Lemos E Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: benefits in type 2 diabetes mellitus. Oxid Med Cell Longev 2012, 2012:741545. 3425959, 22928086, Teixeira de Lemos E.
111. Lees SJ, Booth FW. Sedentary death syndrome. Can J Appl Physiol 2004, 29:447-460. 10.1139/h04-029, 15317985.
112. Norman A, Bellocco R, Vaida F, Wolk A. Total physical activity in relation to age, body mass, health and other factors in a cohort of Swedish men. Int J Obesity 2002, 26:670-675.
113. Sodergren M, Sundquist J, Johansson SE, Sundquist K. Physical activity, exercise and self-rated health: a population-based study from Sweden. BMC Publ Health 2008, 8:352.
114. Darviri C, Fouka G, Gnardellis C, Artemiadis AK, Tigani X, Alexopoulos EC. Determinants of self-rated health in a representative sample of a rural population: a cross-sectional study in Greece. Int J Environ Res Public Health 2012, 9:943-954. 10.3390/ijerph9030943, 3367289, 22690175.
115. Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K, Craighead E, Baldewicz TT, Krishnan R. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med 2000, 62:633-638.
116. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010, 316:129-139. 10.1016/j.mce.2009.08.018, 19723556.
117. Sell H, Eckel J. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care 2010, 13:366-370. 10.1097/MCO.0b013e32833aab7f, 20473150.
118. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone?. Diabetes Care 2003, 26:2442-2450. 10.2337/diacare.26.8.2442, 12882876.
119. Lustig Y, Hemi R, Kanety H. Regulation and function of adiponectin receptors in skeletal muscle. Vitam Horm 2012, 90:95-123.
120. Uceyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 2006, 54:2656-2664. 10.1002/art.22026, 16871547.
121. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010, 10:170-181. 10.1038/nri2711, 20154735.
122. Park HS, Park LY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 2005, 69:29-35. 10.1016/j.diabres.2004.11.007, 15955385.
123. Harford KA, Reynolds CM, McGillicuddy FC, Roche HM. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc 2011, 70:408-417. 10.1017/S0029665111000565, 21835098.
124. Schipper HS, Prakken B, Kalkhoven E, Boes M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab 2012, 23:407-415. 10.1016/j.tem.2012.05.011, 22795937.
125. Antuna-Puente B, Feve B, Fellahi S, Bastard AP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008, 34:2-11. 10.1016/j.diabet.2007.09.004, 18093861.
126. Suganami T, Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 2010, 88:33-39. 10.1189/jlb.0210072, 20360405.
127. Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010, Article ID: 513948.
128. Wilson PW, Grundy SM. The metabolic syndrome: practical guide to origins and treatment: Part I. Circulation 2003, 108:1422-1424. 10.1161/01.CIR.0000089505.34741.E5, 14504251.
129. Helminen EE, Mäntyselkä P, Nykänen I, Kumpusalo E. Far from easy and accurate - detection of metabolic syndrome by general practitioners. BMC Fam Pract 2009, 10:76. 10.1186/1471-2296-10-76, 2789713, 19948040.
130. Golbidi S, Mesdaghinia A, Laher I. Exercise in the metabolic syndrome. Oxid Med Cell Longev 2012, 2012:349710. 3399489, 22829955.
131. Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011, 34:392-397. 10.2337/dc10-1676, 3024355, 21270197.
132. de la Llera MM, McGillicuddy FC, Hinkle CC, Byrne M, Joshi MR, Nguyen V, Tabita-Martinez J, Wolfe ML, Badellino K, Pruscino L, Mehta NN, Asztalos BF, Reilly MP. Inflammation modulates human HDL composition and function in vivo. Atherosclerosis 2012, 222:390-394. 10.1016/j.atherosclerosis.2012.02.032, 22456230.
133. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine 2010, 77:552-557. 10.1016/j.jbspin.2010.09.018, 21067953.
134. Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and the metabolic syndrome at 45 years of age. A cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008, 57:298-305.
135. Schwalfenberg G. Improvement of chronic back pain or failed back surgery with vitamin D repletion: a case series. J Am Board Fam Med 2009, 22:69-74. 10.3122/jabfm.2009.01.080026, 19124636.
136. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359. 10.1001/jama.287.3.356, 11790215.
137. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic Syndrome - a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111:1448-1454. 10.1161/01.CIR.0000158483.13093.9D, 15781756.
138. Blaha M, Elasy TA. Clinical use of the metabolic syndrome: why the confusion?. Clin Diabetes 2006, 24:125-131.
139. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related disease. J Clin Endocrinol Metab 2001, 86:3574-3578. 10.1210/jc.86.8.3574, 11502781.
140. Cordain L, Eades MR, Eades MD. Hyperinsulinemic diseases of civilization: more than just syndrome X. Compar Biochem Physiol 2003, 136:95-112.
141. Cowy S, Hardy RW. The metabolic syndrome: A high-risk state for cancer?. Am J Pathol 2006, 169:1505-1522. 10.2353/ajpath.2006.051090, 1780220, 17071576.
142. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, Brand-Miller JC. Glycemic index, glycemic load, and chronic disease risk-a meta-analysis of observational studies. Am J Clin Nutr 2008, 87:627-637.
143. Heiskanen TH, Niskanen LK, Hintikka JJ, Koivumaa-Honkanen HT, Honkalampi KM, Haatainen KM, Viinamäki HT. Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry 2006, 67:1422-1427. 10.4088/JCP.v67n0913, 17017829.
144. Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry 2008, 69:178-182. 10.4088/JCP.v69n0202, 18232723.
145. Miettola J, Niskanen LK, Viinamäki H, Kumpusalo E. Metabolic syndrome is associated with self-perceived depression. Scand J Prim Health Care 2008, 26:203-210. 10.1080/02813430802117624, 3406636, 18609254.
146. Akbaraly TN, Ancelin ML, Jaussent I, Ritchie C, Barberger-Gateau P, Dufouil C, Kivimaki M, Berr C, Ritchie K. Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Diabetes Care 2011, 34:904-909. 10.2337/dc10-1644, 3064049,3064049, 21346185.
147. Saudny H, Cao Z, Egeland GM. Poor self-reported health and its association with biomarkers among Canadian Inuit. Int J Circumpolar Health 2012, 71:18589. http://dx.doi.org/10.3402/ijch.v71i0.18589.
148. Nijs J, Van Houdenhove B, Oostendorp RA. Recognition of central sensitization in patients with musculoskeletal pain: Application of pain neurophysiology in manual therapy practice. Manual Ther 2010, 15:135-141.
149. Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002, 5:551-559. 10.1097/00075197-200209000-00015, 12172480.
150. Glassman SD, Alegre G, Carreon L, Dimar JR, Johnson JR. Perioperative complications of lumbar instrumentation and fusion in patients with diabetes mellitus. Spine J 2003, 3:496-501. 10.1016/S1529-9430(03)00426-1, 14609695.
151. Helmersson J, Vessby B, Larsson A, Basu S. Association of type 2 diabetes with cylcooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004, 109:1729-1734. 10.1161/01.CIR.0000124718.99562.91, 15037525.
152. Robinson D, Mirovsky Y, Halperin N, Evron Z, Nevo Z. Changes in proteoglycans of intervertebral disc in diabetic patients: a possible cause of increased back pain. Spine 1998, 23:849-856. 10.1097/00007632-199804150-00001, 9580950.
153. Gaida JE, Alfredson H, Kiss ZS, Bass SL, Cook JL. Asymptomatic Achilles tendon pathology is associated with a central fat distribution in men and a peripheral fat distribution in women: a cross sectional study of 298 individuals. BMC Musculoskelet Disord 2010, 11:41. 10.1186/1471-2474-11-41, 2841085, 20196870.